All documents for the EUREKA Eurostars project led by FarmPharma have been validated by the authorities

The consortium agreement for the international consortium formed by FarmPharma AB (publ) (“FarmPharma” or “Company”) to participate in the EUREKA Eurostars program has been validated by Vinnova and Eurostar.

As earlier reported an application of consortium consisted of FarmPharma (which is a coordinator of the consortium), the Karolinska Institute and two organisations from France and Slovenia for the project which is devoted for the development of InterferOX product for sustainable treatment and prevention of viral and bacterial infections in cattle was approved. Today, September 7, after formal submission of critical documents like consortium agreement and ethical protocol, Vinnova granted funding for the Swedish part of the project, as it was planned for 2 years with the total budget of about M€ 1,6. The official start of the project is October 1.

“We are glad to start the project in accordance with our plans. The financing of EUREKA Eurostars gives us the excellent opportunity to jointly develop our product InterferOX which is a game changer in the fight against infections in cattle”, – comments Irina Zaitseva, CEO of FarmPharma.

More about FarmPharma:

FarmPharma AB operates in the development and distribution of veterinary products, and their first product is for prevention and treatment of bacterial and viral infections in cattle without the use of antibiotics. For more info please contact Irina Zaitseva, the company’s CEO.

Video presentation

Follow us on:

LinkedIn

All documents for the EUREKA Eurostars project led by FarmPharma have been validated by the authorities

The consortium agreement for the international consortium formed by FarmPharma AB (publ) (“FarmPharma” or “Company”) to participate in the EUREKA Eurostars program has been validated by Vinnova and Eurostar.

As earlier reported an application of consortium consisted of FarmPharma (which is a coordinator of the consortium), the Karolinska Institute and two organisations from France and Slovenia for the project which is devoted for the development of InterferOX product for sustainable treatment and prevention of viral and bacterial infections in cattle was approved. Today, September 7, after formal submission of critical documents like consortium agreement and ethical protocol, Vinnova granted funding for the Swedish part of the project, as it was planned for 2 years with the total budget of about M€ 1,6. The official start of the project is October 1.

“We are glad to start the project in accordance with our plans. The financing of EUREKA Eurostars gives us the excellent opportunity to jointly develop our product InterferOX which is a game changer in the fight against infections in cattle”, – comments Irina Zaitseva, CEO of FarmPharma.

More about FarmPharma:

FarmPharma AB operates in the development and distribution of veterinary products, and their first product is for prevention and treatment of bacterial and viral infections in cattle without the use of antibiotics. For more info please contact Irina Zaitseva, the company’s CEO.

Video presentation

Follow us on:

LinkedIn